Hailide to Establish Fully-Owned Medical Technology Subsidiary in Zhejiang

Stock News03-30

Zhejiang Hailide New Material Co.,Ltd. (002206.SZ) has announced plans to invest 50 million yuan of its own capital to establish a fully-owned subsidiary, tentatively named Zhejiang Hailide Medical Technology Co., Ltd. The final company name is subject to approval by the relevant administration for market regulation.

The establishment of this subsidiary represents a key strategic move to optimize the company's industrial layout and advance its high-end new materials strategy. This initiative holds significant implications for achieving high-quality development and industrial transformation.

The company has long focused on the research, development, production, and sales of industrial yarn and tire cord fabric. It has established core competitive advantages and deep industrial expertise in areas including polymer material modification, fiber spinning technology, large-scale manufacturing, and comprehensive quality control throughout the production process.

Medical materials and medical fiber materials share technological origins and similar processes with the company's existing core business. This expansion is expected to facilitate the efficient application of core technologies and create synergies within the industrial chain, thereby further enhancing research and development capabilities and increasing product value-added.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1141554405?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-30 16:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1141554405","market":"fut","top_or_hot":-1,"title":"Hailide to Establish Fully-Owned Medical Technology Subsidiary in Zhejiang","media":"Stock News","content":"<p>Zhejiang Hailide New Material Co.,Ltd. (002206.SZ) has announced plans to invest 50 million yuan of its own capital to establish a fully-owned subsidiary, tentatively named Zhejiang Hailide Medical Technology Co., Ltd. The final company name is subject to approval by the relevant administration for market regulation.</p>\n<p>The establishment of this subsidiary represents a key strategic move to optimize the company's industrial layout and advance its high-end new materials strategy. This initiative holds significant implications for achieving high-quality development and industrial transformation.</p>\n<p>The company has long focused on the research, development, production, and sales of industrial yarn and tire cord fabric. It has established core competitive advantages and deep industrial expertise in areas including polymer material modification, fiber spinning technology, large-scale manufacturing, and comprehensive quality control throughout the production process.</p>\n<p>Medical materials and medical fiber materials share technological origins and similar processes with the company's existing core business. This expansion is expected to facilitate the efficient application of core technologies and create synergies within the industrial chain, thereby further enhancing research and development capabilities and increasing product value-added.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hailide to Establish Fully-Owned Medical Technology Subsidiary in Zhejiang</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHailide to Establish Fully-Owned Medical Technology Subsidiary in Zhejiang\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-03-30 16:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zhejiang Hailide New Material Co.,Ltd. (002206.SZ) has announced plans to invest 50 million yuan of its own capital to establish a fully-owned subsidiary, tentatively named Zhejiang Hailide Medical Technology Co., Ltd. The final company name is subject to approval by the relevant administration for market regulation.</p>\n<p>The establishment of this subsidiary represents a key strategic move to optimize the company's industrial layout and advance its high-end new materials strategy. This initiative holds significant implications for achieving high-quality development and industrial transformation.</p>\n<p>The company has long focused on the research, development, production, and sales of industrial yarn and tire cord fabric. It has established core competitive advantages and deep industrial expertise in areas including polymer material modification, fiber spinning technology, large-scale manufacturing, and comprehensive quality control throughout the production process.</p>\n<p>Medical materials and medical fiber materials share technological origins and similar processes with the company's existing core business. This expansion is expected to facilitate the efficient application of core technologies and create synergies within the industrial chain, thereby further enhancing research and development capabilities and increasing product value-added.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0201","symbol_name":"可转债","start_time":0,"source_url":"","article_id":"1141554405","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1141554405","pubTimestamp":1774859447,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Zhejiang Hailide New Material Co.,Ltd. (002206.SZ) has announced plans to invest 50 million yuan of its own capital to establish a fully-owned subsidiary, tentatively named Zhejiang Hailide Medical...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159891":"医疗","BK0201":"可转债","BK0208":"化学纤维","002206":"海利得"},"translate_title":"海利得将在浙江设立医疗科技全资子公司","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159891":1,"002206":1},"content_text":"Zhejiang Hailide New Material Co.,Ltd. (002206.SZ) has announced plans to invest 50 million yuan of its own capital to establish a fully-owned subsidiary, tentatively named Zhejiang Hailide Medical Technology Co., Ltd. The final company name is subject to approval by the relevant administration for market regulation.\nThe establishment of this subsidiary represents a key strategic move to optimize the company's industrial layout and advance its high-end new materials strategy. This initiative holds significant implications for achieving high-quality development and industrial transformation.\nThe company has long focused on the research, development, production, and sales of industrial yarn and tire cord fabric. It has established core competitive advantages and deep industrial expertise in areas including polymer material modification, fiber spinning technology, large-scale manufacturing, and comprehensive quality control throughout the production process.\nMedical materials and medical fiber materials share technological origins and similar processes with the company's existing core business. This expansion is expected to facilitate the efficient application of core technologies and create synergies within the industrial chain, thereby further enhancing research and development capabilities and increasing product value-added.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1141554405","isCrawlerRequest":true}